Skip to content

Preoperative intravenous prophylactic analgesia with acetaminophen mannitol injection in breast surgery patients: A single center, randomized, controlled study

Preoperative intravenous prophylactic analgesia with acetaminophen mannitol injection in breast surgery patients: A single center, randomized, controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074555
Enrollment
Unknown
Registered
2023-08-09
Start date
2023-03-13
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing breast surgery under general anesthesia

Interventions

Control group:No drug use before surgery
Experimental group:Acetaminophen mannitol injection 500mg, intravenous injection 15min

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Those who plan to undergo elective breast surgery under general anesthesia; (2) Age 18-50 years old, BMI 15-40 kg/m2, ASA I-III grade; (3) Able to understand and sign informed consent forms, and cooperate in completing interventions and evaluations.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating patients; (2) Determine/suspect a history of alcohol, opioid, or other substance abuse; (3) Postoperative ICU admission; (4) Participate in other clinical studies within 3 months prior to enrollment in this study.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
Number of cases of nausea and vomiting;Intraoperative remifentanil dosage;Number of cases of analgesic remedy within 48 hours after surgery;Postoperative hospitalization days and total hospitalization days;PONV related complications 30 days after surgery;

Countries

China

Contacts

Public ContactZhifeng Lyu

The First Affiliated Hospital of Henan University of Chinese Medicine

mazui1846@126.com+86 135 2678 5785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026